We have previously shown by far-Western blotting that the Epstein-Barr virus nuclear antigen 2 (EBNA-2) both binds to a cellular protein of 130 kDa and histone H1, with the complex between EBNA-2 and p130 being tighter than between EBNA-2 and histone H1. Here we demonstrate that the N terminus of EBNA-2, which was previously shown to be necessary for transformation of B lymphocytes by EBNA-2, is essential for binding to p130. We further show data indicating that the binding of EBNA-2 to histone H1 appears not to be mediated exclusively via the basic Arg-Gly rich region in the Cterminal part of EBNA-2. With a MAb directed against the Trp-Trp3~2-Pro (WWP) motif of EBNA-2, which is known to be essential for the interaction of EBNA-2 with the cellular factor RBPJ~/CBF1, we could inhibit the DNA binding of EBNA-2, providing further evidence that this region of EBNA-2 forms direct contact with RBPJ~/CBF1.
TP1, TP2 and LMP1 genes and stimulates transcription from the virus BamHI C promoter (for review see Middleton et al., 1991) . Several studies recently revealed that EBNA-2 exerts its transactivational function indirectly, mainly by interacting with the cellular DNAbinding protein RBPJ~, which was found to bind to its recognition sequence in the EBNA-2 response elements of the LMP1, CD23, TP1 and BamHI C promoters (Zimber-Strobl et al., 1994; Henkel et al., 1994; . EBNA-2 interacts with RBPJ~ both in the presence and absence of a DNA-binding site and it is suggested that RBPJ~ tethers EBNA-2 to its response elements (Hsieh & Hayward, 1995) . The transcription factor Spi-1/PU.1 was shown to bind to an EBNA-2 response element in the LMP1 promoter thus conferring EBNA-2 responsiveness to this promoter (Laux et al., 1994) . Recently it was shown that the EBNA-2 Cterminal acidic domain is able to interact with TFIIB, TFIIH, TAF40 and a novel nuclear protein, pl00 (Tong et al., 1995) .
Using the far-Western blotting technique, we showed that EBNA-2 is able to interact with histone H1 (Gr/isser et al., 1993) . Numbers at the top refer to the EBNA-2 amino acid sequence of the strain M-ABA. P, polyproline domain; Divergent, sequence between EBNA-2A and EBNA-2B; RG, Arg-Gly repeat motif; neg, negatively charged domain. Solid bars indicate the length of the inserted linker. The sites of the point mutants are indicated by vertical bars. Hc24AH37, amino acids 1%197 deleted; H20AH28, d148-336; H37AH21, d197-322; ASph, d246-381; ANco, d322-369; H28AA63, d336~467; KT3, the nine Cterminal amino acids of EBNA-2 were replaced by the 11 C-terminal amino acids of the simian virus 40 large T antigen (KPPTPPPEPET); ANcoKT3, combination of ANco and KT3; Hae21, linker insertion (LE) at position 322 within the Trp-Trp322-Pro motif; SC, Cys 32~ replaced by serine; CS, Cys 41° replaced by serine; SS, both cysteines replaced by serines. ND, Not determined. (b) Western-blot analysis (see Billaud et al., 1989 for description) of some of the EBNA-2 mutants expressed in the baculovirus system. The recombinant baculovirus expressing full-length EBNA-2 was described previously (Grfisser et al., 1993) . Recombinant association of EBNA-2 with a 130 kDa protein and suggested that p 130 plays a role in the EBNA-2-mediated transformation process (Gr~isser et al., 1993) . At the beginning of our studies the protein responsible for targeting EBNA-2 to its promoter response elements had not been identified and we therefore wanted to know whether p 130 was involved in DNA binding. To address this question we tried to identify the regions of EBNA-2 responsible for interaction with the promoter-binding protein and with p130. Moreover we wanted to investigate the role of cysteine residues 326 and 410 of EBNA-2 from strain M-ABA (Tsui & Schubach, 1994) in DNA binding. A series of deletion, linker insertion and point mutations of EBNA-2 was created as summarized in Fig.  1 (a) . If p130 is involved in DNA binding and transformation, one of the four regions of EBNA-2 previously determined by Cohen et al. (1991) to be essential in terms of transformation and transactivation should also be necessary for binding to p130. Thus, the linker insertion mutants Hae21 and ANco, which are almost identical to mutants T1EBNA-21i320 and T1EBNA-2A321-378 (Cohen et al., 1991) , were included in our study. These latter mutants have previously been shown to be non-transforming and not transactivating (Cohen et al., 1991) . All of the mutants were expressed in vitro by transcription-translation to test for their ability to bind indirectly to the TP1 promoter in an electrophoretic mobility shift assay (EMSA). Deletion and insertion mutants spanning almost all of the EBNA-2-coding region were expressed in the baculovirus system to test for their ability to bind to p130 and histone H1 in far-Western blotting. Details about the construction of the mutants and the vectors for expression in vitro and by baculovirus can be obtained from the authors upon request. Western blot analysis of the mutants expressed in insect cells is shown in Fig. 1 (b) . MAb R3 recognizes a C-terminal epitope which is deleted in the C-terminal mutant H28AA63. To detect this mutant, MAb 6C8 was raised against a peptide containing the EBNA-2 TrpTrp322-Pro ('WWP') motif ( Fig. 1 ), because this motif was shown to be necessary for transformation and binding to RBPJ~ (Cohen et al., 1991 ; Ling & Hayward, 1995) . We analysed the mutants for their ability to bind to the 130 kDa protein and histone H1 in far-Western blot analysis as shown in Fig. 2 . Our results revealed that deletions in the C-terminal and central parts of EBNA-2 (mutants H28AA63, H37AH21 and ANcoKT3, respectively) had no effect on the ability of EBNA-2 to bind to p130 whereas deletion of the N-terminal amino acids 18 to 197 (mutant H24AH37) resulted in an almost complete loss of binding (Fig. 2a) . The linker-insertion mutant Hae21 was still able to bind to p130. We have previously shown that EBNA-2 is able to form high molecular mass complexes sedimenting at 13S and 34S (Gr/isser et al., 1991) . Our previous studies suggest that the 34S complex may result in part from oligomerization of EBNA-2 and these findings further suggest that two domains of EBNA-2, one between amino acids 122 and 232 and another between amino acids 232 and 344, are important for self-association (Tsui & Schubach, 1994) . The failure of the N-terminal deletion mutant H24AH37 to bind to p130 could be due to the deletion of an epitope that mediates the association with p130. Alternatively, the deleted region of H24AH37 could be essential for the oligomerization of EBNA-2, which in turn might only be able to bind to p130 as an oligomer.
Our finding that EBNA-2 expressed in insect cells is able to interact with histone H1 in vitro is consistent with the observation that EBNA-2 can be found in the chromatin fraction (Gr/isser et al., 1991) . Meanwhile, Tong et al. (1994) have confirmed the association of EBNA-2 with histone H1 in vitro and furthermore showed that a fusion protein between glutathione Stransferase and amino acids 335 to 360 from EBNA-2 is able to bind to histone H1 in far-Western blot analysis. These and other data suggest that the interaction between EBNA-2 and histone H1 is mediated via the basic ArgGly domain of EBNA-2. We also tested our EBNA-2 mutants for their ability to associate with histone H1 in far-Western blotting (Fig. 2a, b ). All mutants tested were able to bind to histone H 1 and no significant differences in the amount of bound EBNA-2 were observed. This was surprising in that the mutants ANcoKT3 and H28AA63 are completely deleted in the Arg-Gly region but still bound to histone H1 (Fig. 2a, b) . We therefore hypothesize that the interaction of EBNA-2 with histone H 1 might be mediated via more than one domain, thus explaining why these two mutants were still able to bind HI.
In order to investigate which regions of EBNA-2 are essential for indirect binding to DNA, all the mutants baculoviruses expressing the mutant EBNA-2 proteins were generated by cotransfection of Spodopterafrugiperda Sf158 cells with the respective recombinant baculovirus transfer vectors (pACYM 1 was used for all plasmid constructions) and linearized BaculoGold virus DNA (Pharmingen) using lipofection as described (see King & Possee, 1992 for details and references). MAbs R3 (rat IgG2a; Kremmer et al., 1995) and 6C8 (rat IgG2a) were used for detection of the EBNA-2 proteins. MAb 6C8 (rat IgG2a) was raised against peptide DDDSGPPWWPPISD (amino acids underlined correspond to EBNA-2 amino acids 317-327 of EBV strain M-ABA; Cyst zzn is replaced by serine) in Lou/C rats exactly as described (Kremmer et al., 1995) . bac-wt, Extract of insect cells infected with wild-type baculovirus as negative control; E2-wt, wild-type EBNA-2. The positions of molecular mass marker proteins (Pharmacia) are indicated. , 1993) . Whole cell extracts of the EBNA-2-negative cell line P3HR1 (lanes 1 7) were electrophoresed on a 10% SDS-polyacrylamide gel and transferred to nitrocellulose. The membrane was cut into strips and these were probed in a total volume of 3.1 ml containing 0.1 ml extract from insect cells infected with wild-type virus (bac-wt), recombinant viruses coding for the expression of wild-type EBNA-2 (E2-wt) or some of the EBNA-2 mutants, as indicated. Bound proteins were visualized using either MAb R3 (lanes 1-6) or MAb 6C8 (lane 7). Extracts from baculovirus-infected cells were prepared by suspending 1 x l0 T Sf158 cells infected with wild-type or recombinant baculovirus in 0-5 ml lysis buffer (100 mM-Tris-HCl pH 9.0, 100 mM-NaCI, 5 mMMgCI~, 1 mM-CaC12, 0"5 % Triton X-100). Upper arrow, position of the cellular 130 kDa protein; lower arrow, position of histone H1. (b) FarWestern blot using histone H1. Purified histone HI (Gr~isser et al., 1993) was electrophoresed on a 15% polyacrylamide gel and transferred to nitrocellulose. Lanes 7 and 12, purified histone H1 stained with amido black after transfer to nitrocellulose. Lanes 1-6 and 8 10, incubation of the strips as indicated. Lane 11, incubation of the strip with incubation buffer in the absence of insect cell extract. Strips 1-5 and 8-11, incubation with MAb R3; Strip 6, incubation with MAb 6C8. Strips 1 7 and 8 12 were taken from two different gels. Positions of molecular mass markers are indicated.
were transcribed-translated /n vitro using plasmid pSPT19 (Boehringer Mannheim) as the & vitro transcription vector. The respective recombinant pSPT19 plasmids were digested with SalI and transcribed using SP6 R N A polymerase and a Boehringer Mannheim & vitro transcription kit. The resultant R N A was translated in vitro using a Promega reticulocyte lysate translation kit. By Western blot analysis we confirmed that all mutants showed the expected migration behaviour and were expressed at similar levels (data not shown). The ability of the various mutants to indirectly bind to a 54 bp TP1 promoter fragment was tested by EMSA as described (Sauder et al., 1994) . We observed that the cysteine mutants bound to the TP1 promoter with equal efficiency as the wild-type protein and the linker insertion/deletion mutant KT3 (data not shown). Of the remaining deletion mutants, only the N-terminal mutant Hc24AH37 yielded a signal in the EMSA (Fig. 3 a; data not shown). As expected from previously published experiments, no binding of the linker insertion mutant Hae21 was detected (data not shown). The failure of the deletion mutants H20AH28, ASph, H37AH21, ANco and ANcoKT3 and of the insertion mutant Hae21 to bind to the D N A is consistent with the idea that EBNA-2 interacts with RBPJ~ via the WWP motif (Trp-Trp a~2-Pro), which is deleted or modified in all of these mutants. In a competition experiment using a peptide containing this motif, Ling & Hayward (1995) recently showed that the interaction between full-length EBNA-2 and RBPJ~ could be prevented in an EMSA, implying that EBNA-2 mediates interaction with RBPJ~ directly via the WWP motif. Assuming this, MAb 6C8, which was raised against the W W P motif (Fig. 1 b) , should be able to prevent the association between EBNA-2 and RBPJ~. In the experiment presented in Fig. 3 (a) we show that addition of MAb 6C8 to the complex between EBNA-2 and RPBJ~ results in a dissociation of this complex because no more shift or supershift could be detected in the autoradiograph (lanes 5 and 11). In lane 8, & vitrotranslated EBNA-2 was incubated with MAb 6C8 prior to addition of EBNA-2-negative nuclear extract, which also led to the same effect as shown in lanes 5 and 11. This experiment provides further evidence for a direct interaction of EBNA-2 with RBPJ~ via the WWP motif. By addition of the peptide containing the W W P motif used for the generation of MAb 6C8 to the complex of EBNA-2/RBPJ~ bound to the target DNA, we also observed that EBNA-2 was released by this peptide from the D N A as previously shown by Ling & Hayward (1995) (data not shown). The C-terminal mutant H28AA63 did not bind to the D N A even though the WWP motif was not deleted. This finding is in good agreement with recently published data by Ling & Hayward (1995) , which suggest that regions adjacent to Fig. 3 . Analysis of the ability of the EBNA-2 mutant H24AH37 to bind indirectly to a 54 bp TPt promoter oligonucleotide (a) and interruption of the interaction of EBNA-2 with RBPJ~ using a MAb (b). Gel shift reactions were carried out with nuclear extracts of the EBNA-2-negative cell line BL41-P3HR1 or the EBNA-2-positive cell line IB4. Three gl of in vitro-translated protein (i.v.t. protein) containing wild-type EBNA-2 (E2-wt), EBNA2-H24AH37 or in vitro-translated brome mosaic virus RNA (BM) and 3 lal supernatant of either MAb R3 (see Fig. 1 b) , MAb 6C8 (see Fig. 1 b) or anti-mouse CD45 (IgG2a) MAb (as a control) were added as indicated. Complexes I and III represent binding of RBPJ~ to one (I) and two (III) binding sites in the 54 bp TP1 oligonucleotide (see ZimberStrobl et al., 1994) . Complex II represents binding of the mutant H24AH37 to RBPJK, bound to one binding site only because the hypothetical complex consisting of the mutant EBNA-2 plus RBPJ K bound to both sites, expected to migrate between complexes III and IV, was not observed. II* indicates complex II supershifted with MAb R3 ; IV, complex formed in the presence of in vitro-translated wild-type EBNA-2 or virus EBNA-2 (see Zimber-Strobl et al., 1994) ; IV*, complex supershifted with MAb R3; lanes 8-10 (b), in vitrotranslated EBNA-2 was first incubated with the respective antibodies and then mixed with the remaining components.
the WWP motif are necessary to ensure a stable interaction between EBNA-2 and RBPJ K, at least under the conditions of an EMSA. As mentioned, the cysteine mutants were still able to form complexes with the TP1 promoter in the EMSA. A study to test the ability of these mutants to transactivate transcription of a TPl-luciferase reporter gene construct in cotransfection assays using the EBNA-2-negative cell line BL41-P3HR1 revealed that mutation of the cysteines did not lead to an abrogation of the ability to transactivate. This suggests that the cysteine residues of EBNA-2 do not play a crucial role in the function of the protein, at least in terms of DNA-binding and transactivation of the TP1 promoter (C. Zabel, C. Sauder, U. Zimber-Strobl, N. MueUer-Lantzsch & F. A. Gr~isser, unpublished results).
The results from far-Western blotting and DNAbinding analyses are summarized in Fig. 1 (a) . The mutants H37AH21, H28AA63, ANcoKT3 and Hae21, which did not indirectly bind to the D N A in the EMSA, were still able to associate with the 130 kDa protein, whereas the N-terminal mutant H24AH37, which retained the ability to bind indirectly to the DNA, showed a markedly reduced association with the 130 kDa protein. Based on these data, we therefore exclude the involvement of the 130 kDa protein in DNA binding, while it is clear that the 63 kDa protein RBPJ~ mediates the interaction between EBNA-2 and its DNA response elements. The mutant T1EBNA-2A19-110 was previously shown by Cohen et al. (1991) to be inactive in both transactivation and transformation assays. Because the N-terminal region deleted in this mutant is covered by the mutant H24AH37 used in our study and because this region is necessary for the interaction between EBNA-2 and the 130 kDa protein, our data suggest that the 130 kDa protein may play a role in the EBNA-2-mediated process of transformation. Studies using the yeast two hybrid system are underway to identify this protein.
